Clear cell sarcoma in the era of sentinel lymph node mapping

Journal of Surgical Oncology

Volumn 87, Issue 3, 2004, Pages 126-129

  Al Refaie, Waddah B ^a   Ali, Mir W ^a   Chu, David Z ^b   Paz, Isaac B ^b   Blair, Sarah L ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Blue dye; Clear cell sarcoma; Lymphoscintigraphy; Sentinel lymph node biopsy

Indexed keywords

ADULT; ARTICLE; BELOW KNEE AMPUTATION; BONE METASTASIS; CASE REPORT; CLEAR CELL SARCOMA; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SOFT TISSUE TUMOR;

ADULT; FASCIA; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; PROGNOSIS; SARCOMA, CLEAR CELL; SENTINEL LYMPH NODE BIOPSY; SOFT TISSUE NEOPLASMS; TENDONS;

EID: 4444343646     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20096     Document Type: Article

References (22)

1. Chung EB, Enzinger FM: Malignant melanoma of soft parts. A reassessment of clear cell sarcoma. Am J Surg Pathol 1983;7: 405-413.
2. Mukai M, Torikata C, Iri H, et al.: Histogenesis of clear cell sarcoma of tendons and aponeuroses: An electron-microscopic, biochemical, enzyme histochemical, and immunohistochemical study. Am J Pathol 1984;114:265-272.
3. Weiss SW, Langloss JM, Enzinger FM: Value of s-100 protein in the diagnosis of soft tissue tumors and particular reference to benign and malignant Schwann cell tumors. Lab Invest 1983;49: 299-330.
4. Enzinger F: Clear cell sarcoma of the tendons and aponeuroses: An analysis of 21 cases. Cancer 1965;18:1163-1174.
5. Deenik W, Mooi WJ, Rutgers EJ, et al.: Clear cell sarcoma (malignant melanoma) of soft parts: A clinicopathologic study of 30 cases. Cancer 1999;86:969-975.
6. Eckardt JJ, Pritchard DJ, Soule EH: Clear cell sarcoma. A clinicopathologic study of 27 cases. Cancer 1983;52:1482-1488.
7. Finley JW, Hanypsiak B, McGrath B, et al.: Clear cell sarcoma: The Roswell Park experience. J Surg Oncol 2001;77: 16-20.
8. Morton DL, Wen DR, Wong JH, et al.: Technical details of intraoperative lymphatic mapping for early stages melanoma. Arch Surg 1992;127:392-399.
9. Morton DL, Wen DR, Foshag LJ, et al.: Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J Clin Oncol 1993;11:1751-1756.
10. Giuliano AE, Kirgan DM, Guenther JM, et al.: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-398.
11. Chao C, McMasters KM: Update on the use of sentinel node biopsy in patients with melanoma: Who and how. Curr Opin Oncol 2002;14:217-220.
12. Hsueh EC, Hansen N, Giuliano AE: Intraoperative lymphatic mapping and sentinel lymph node dissection in breast cancer. CA Cancer J Clin 2000;50:279-291.
13. Hill AD, Brady MS, Coit DG: Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg 1999;86:518-521.
14. Zervos EE, Burak WE, Jr.: Lymphatic mapping in solid neoplasms: State of the art. Cancer Control 2002;9:189-202.
15. Blazer DG, Sabel MS, Sondak VK: Is there a role for sentinel lymph node biopsy in the management of sarcoma? Surg Oncol 2003;12:201-206.
16. Cascinelli N, Belli F, Santinami M, et al.: WHO Melanoma Programme: Results of sentinel node study. Melanoma Res 2001; 11:221.
17. Jacobs IA, Chevinsky AH, Swayne LC, et al.: Gamma probe-directed lymphatic mapping and sentinel lymphadenectomy in primary melanoma: Reliability of the procedure and analysis of failures after long-term follow-up. J Surg Oncol 2001;77:157-164.
18. Estourgie SH, Nieweg OE, Valdes Olmos RA, et al.: Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol 2003;10: 681-688.
19. Harlow SP, Krag DN, Ashikaga T, et al.: Gamma probe guided biopsy of the sentinel node in malignant melanoma: A multicentre study. Melanoma Res 2001;11:45-55.
20. Caraco C, Chiofalo MG, Niro J, et al.: Sentinel Lymph node biopsy to stage patients with cutaneous melanoma at the National Cancer Institute of Naples. Results from 240 sentinel node biopsies. Tumori 2002;88:S12-S13.
21. Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, et al.: Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes-One institution's experience. Melanoma Res 2003;13:35-43.
22. Chao C, Wong SL, Ross MI, et al.: Patterns of early recurrence after sentinel lymph node biopsy for melanoma. Am J Surg 2002; 184:520-524.